Intensiva Healthcare Corporation

Ticker:	IHCC	7733 Forsyth Boulevard, 11th Floor
Exchange:	NASDAQ-National Market	St. Louis, Missouri 63105
Industry:	Service	(314) 725-0112

Type of Shares:	Common Shares	Filing Date:	7/26/96
U.S. Shares:	2,500,000	Offer Date:	10/10/96
Non-U.S. Shares:	0	Filing Range:	$11.00 - $13.00
Primary Shares:	2,500,000	Offer Price:	$6.00
Secondary Shares:	0	Gross Spread:	$0.42
Offering Amount:	$30,000,000	Selling:	$0.23
Expenses:	$600,000	Reallowance:	$0.10
Shares Out After:	9,530,067

Manager	Tier	Phone
Hambrecht & Quist Incorporated	Lead Manager	(415) 576-3423
Needham & Company	Co-manager	(212) 371-8300
Robertson, Stephens & Company	Co-manager	(415) 989-8500

Auditor: KPMG Peat Marwick
		6 Month Ending Financials
	Audited Income	Latest Unaudited Income	Prior Unaudited Income		Balance Sheet
	12/31/95	6/30/96	6/30/95		6/30/96
Revenue:	$1.49	$6.08	$0.17	Assets:	$13.43
Net Income:	-$2.85	-$1.75	-$1.20	Liabilities:	$3.39
EPS:	-$0.39	-$0.24		Equity:	$10.04
Note: Dollar amounts are in U.S. millions; Audited figures expressed as full year, unaudited figures are partial year

Business Description

The company provides specialized, acute long term patient care for critically ill or injured patients. The company provides high quality, cost effective, specialized care for its patients, who typically require an average length of stay of greater than 25 days in an intensive inpatient setting. Intensiva's medical staff provide specialized medical services, as well as nursing and respiratory care, and the company is developing disease-specific pathways to treat patients with pulmonary, cancer, renal and cardiac conditions, among others. The company's clinical programs utilize specialized staff, equipment and protocols for the treatment of its patients.

Use of Proceeds

The proceeds from the offering will be used for development and operation of additional facilities, acquisitions, working capital and for general corporate purposes including possible acquisitions.

Last updated: 12/22/96